StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) Adds to Gains on Rumor
March 16, 2016 10:12 AM
Valeant Pharma (NYSE: VRX) is adding to early gains on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Rumors
Short Sales
Trader Talk
Next Articles
Valeant Pharma (VRX) Price Target Lowered to $45 at TD Securities
March 16, 2016 11:16 AM
Mallinckrodt (MNK) Under Pressure Again as Citron, CEO Duke It Out on CNBC (VIDEO)
March 16, 2016 9:58 AM
Valeant Pharma (VRX) Sees Early Upside after Massive Beating
March 16, 2016 9:48 AM
Valeant (VRX) PT Cut to $40 at Canaccord Genuity
March 16, 2016 9:40 AM
Valeant (VRX) Default 'Unlikely', Says Rodman & Renshaw
March 16, 2016 7:43 AM
Nomura Securities Downgrades Valeant Pharmaceuticals (VRX) to Neutral
March 16, 2016 6:55 AM
Form 4 Valeant Pharmaceuticals For: Mar 11 Filed by: Ross Thomas W. Sr.
March 15, 2016 5:59 PM
Form 4 Valeant Pharmaceuticals For: Mar 11 Filed by: ESHELMAN FREDRIC N
March 15, 2016 5:56 PM
CIBC Downgrades Valeant Pharmaceuticals (VRX) to Sector Underperform
March 15, 2016 5:38 PM
